Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intestinal bacteria and the hydrolysis of glycosidic bonds.

× No keyword cloud information.

50 in total

1. Heterologously expressed family 51 alpha-L-arabinofuranosidases from Oenococcus oeni and Lactobacillus brevis.

Authors: Herbert Michlmayr; Christina Schümann; Klaus D Kulbe; Andrés M del Hierro
Journal: Appl Environ Microbiol Date: 2010-12-17 Impact factor: 4.792

2. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.

Authors: B R Goldin; S L Gorbach; M Saxelin; S Barakat; L Gualtieri; S Salminen
Journal: Dig Dis Sci Date: 1992-01 Impact factor: 3.199

Review 3. The conduct of drug metabolism studies considered good practice (I): analytical systems and in vivo studies.

Authors: Xiaodong Liu; Lee Jia
Journal: Curr Drug Metab Date: 2007-12 Impact factor: 3.731

4. The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery.

Authors: D A Adkin; C J Kenyon; E I Lerner; I Landau; E Strauss; D Caron; A Penhasi; A Rubinstein; I R Wilding
Journal: Pharm Res Date: 1997-01 Impact factor: 4.200

5. Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.

Authors: Rajkumar Malayandi; Phani Krishna Kondamudi; P K Ruby; Deepika Aggarwal
Journal: Drug Deliv Transl Res Date: 2014-04 Impact factor: 4.617

10. Ultrastructural visualization of galactosyl residues in various alimentary epithelial cells with the peanut lectin-horseradish peroxidase procedure.

Authors: A Sato; S S Spicer
Journal: Histochemistry Date: 1982

Intestinal bacteria and the hydrolysis of glycosidic bonds.

1. Heterologously expressed family 51 alpha-L-arabinofuranosidases from Oenococcus oeni and Lactobacillus brevis.

2. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.

Review 3. The conduct of drug metabolism studies considered good practice (I): analytical systems and in vivo studies.

4. The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery.

5. Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.

6. In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.

7. Ubiquitous presence of beta-glucuronidase (GUS) in plants and its regulation in some model plants.

Review 8. Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies.

9. Colon delivery of budesonide: evaluation of chitosan-chondroitin sulfate interpolymer complex.

10. Ultrastructural visualization of galactosyl residues in various alimentary epithelial cells with the peanut lectin-horseradish peroxidase procedure.